• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Discovery Behavioral Health Acquires Casa Palmera

Share:

December 23, 2019

Putting puzzle pieces together on sky background with sunlight

Discovery Behavioral Health, a nationwide leader in behavioral health services, has acquired Casa Palmera in San Diego, California, a nationally-recognized facility providing evidence-based treatment for adults dealing with drug and alcohol addiction.

The staff of Casa Palmera consists of licensed professionals including a medical doctor, psychiatrists, clinical psychologists, registered nurses, social workers, and master’s level therapists. Treatments take place in a residential community situated along the San Dieguito River Valley, three miles inland from coastal Del Mar, California.

“We recognize the growing unmet needs of those struggling with substance use and mental health disorders,” said Joe Tinervin, division president for Discovery Behavioral Health. “Our acquisition of Casa Palmera helps us further solidify and enhance our continuum of stellar behavioral health services while meeting the needs of this population. We are poised to help ensure more people can gain access to affordable, quality treatment.”

In addition to the acquisition, Discovery Behavioral Health will enhance the Casa Palmera team with seasoned industry professionals. Joining as national director of outreach for the Substance Use Division is Jonathan Gross, formerly of Recovery Ways in Salt Lake City, UT, where he served as national director of referral relations, overseeing professionals in markets across the United States, as well as the Hawaiian Islands. Specializing in substance abuse and complex co-occurring mental health disorders, Gross has worked in a variety of roles within behavioral healthcare over the past decade.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Also onboard is Christina Hammett, regional director of clinical outreach of the Substance Use Division for Discovery Behavioral Health. Hammett brings nearly 20 years of experience in the medical/behavioral health field, including positions with Promises Behavioral Health and GlaxoSmithKline.

John Peloquin, president & CEO of Discovery Behavioral Health stated, “Our acquisition of Casa Palmera further enhances our ability to provide proven, clinically-sound, affordable addiction treatment to California and beyond. This acquisition brings us one step closer to changing the paradigm for how Substance Use Disorder treatment is conducted in America.”

Source: BioSpace

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • UCLA Spin Out DEARhealth Lands $6M for AI-Powered Pathways for Power CareUCLA Spin Out DEARhealth Lands $6M for AI-Powered Pathways for Power Care
  • FDA Streamlines Biosimilar Approval ProcessFDA Streamlines Biosimilar Approval Process
  • Fitbit Launches New Research Pledge to Address Evolving Privacy RisksFitbit Launches New Research Pledge to Address Evolving Privacy Risks
  • FDA Grants Priority Review to Takeda’s Dengue VaccineFDA Grants Priority Review to Takeda’s Dengue Vaccine
  • Arteaus Therapeutics Sells Emgality Royalty for $260 MillionArteaus Therapeutics Sells Emgality Royalty for $260 Million
  • Blurring of lines between medicines and medical devices is confusing authorisation process, MHRA warnsBlurring of lines between medicines and medical devices is confusing authorisation process, MHRA warns
  • Sentara Health Innovates with AI for CliniciansSentara Health Innovates with AI for Clinicians
  • Mainz Biomed Enters Commercial Partnerships for ColoAlert with Two Independent LaboratoriesMainz Biomed Enters Commercial Partnerships for ColoAlert with Two Independent Laboratories

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications